Proposed mechanisms for the origin of ER− breast cancers include that of pressures being exerted on ER+ cells by oestrogen withdrawal, hypoxia, or overexpression of epidermal growth factor receptor or ErbB2 resulting in MAPK hyperactivation (Creighton et al, 2006). This evidence concerns the gene ERBB2 and breast cancer.